Electric pulse treatment for early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new treatment that uses electric pulses to destroy early-stage lung tumors without surgery. It is for people who cannot have surgery or radiation, or who choose not to.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 79 years old.
- You have early-stage non-small cell lung cancer (the most common type of lung cancer) or lung tumors that spread from another cancer (called oligometastases).
- The tumor(s) must be 3 cm or smaller in size, and you can have up to 3 tumors in one lung (or up to 5 in total if they spread).
- You are not able to have surgery or radiation, or you have decided not to have them.
- You agree to receive ablation therapy (a treatment that uses electric pulses to destroy the tumor) and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that uses brief electrical pulses (pulsed electric field or PEF) to treat lung tumors before they are surgically removed. The goal is to see if this approach can be safely added to standard lung cancer surgery.
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
This study tests whether adding electro-acupuncture (a gentle type of acupuncture with mild electrical pulses) to standard first-line immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer. It aims to see if this combination improves quality of life and overall treatment outcomes.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial tests a wearable device that uses electric fields (called tumor treating fields) before surgery for early-stage non-small cell lung cancer. The goal is to see if it can help shrink the tumor and improve outcomes for patients.
This trial tests a new treatment that uses short electric pulses (pulsed electric field) to target and damage cancer cells in the esophagus. It is for people with advanced esophageal cancer that cannot be removed by surgery, and it aims to be safe and potentially shrink or slow the tumor.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.